BRPI0518552A2 - formulaÇço para o bem estar em seres humanos e mÉtodo para aumentar o bem-estar de um paciente humano - Google Patents

formulaÇço para o bem estar em seres humanos e mÉtodo para aumentar o bem-estar de um paciente humano

Info

Publication number
BRPI0518552A2
BRPI0518552A2 BRPI0518552-1A BRPI0518552A BRPI0518552A2 BR PI0518552 A2 BRPI0518552 A2 BR PI0518552A2 BR PI0518552 A BRPI0518552 A BR PI0518552A BR PI0518552 A2 BRPI0518552 A2 BR PI0518552A2
Authority
BR
Brazil
Prior art keywords
welfare
formulation
humans
wellness
human patient
Prior art date
Application number
BRPI0518552-1A
Other languages
English (en)
Inventor
Phillips Jon
Original Assignee
Dolphst Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907339A external-priority patent/AU2004907339A0/en
Application filed by Dolphst Pty Ltd filed Critical Dolphst Pty Ltd
Publication of BRPI0518552A2 publication Critical patent/BRPI0518552A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)

Abstract

FORMULAÇçO PARA O BEM ESTAR EM SERES HUMANOS E MÉTODO PARA AUMENTAR O BEM-ESTAR DE UM PACIENTE HUMANO. Uma formulação para o bem estar em seres humanos incluindo: extrato de variedades de ervas, Polygonum multiflorum, panax quinquefolium, gingko biloba, e equisetum arvense; beta sitosterol metil sulfonil metano; isoflavonas de soja; levo-arginina; inositol; niacina; ácido pantotênico ou sais do mesmo; alfa-tocoferol; biotina; zinco cloreto de piridoxina (ou um aminoácido quelato do mesmo) e colostro.
BRPI0518552-1A 2004-12-24 2005-12-23 formulaÇço para o bem estar em seres humanos e mÉtodo para aumentar o bem-estar de um paciente humano BRPI0518552A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004907339A AU2004907339A0 (en) 2004-12-24 Formulations and Treatments for Well-Being
AU2005903864A AU2005903864A0 (en) 2005-07-21 Formulations and Treatments for Well-Being
PCT/AU2005/001966 WO2006066354A1 (en) 2004-12-24 2005-12-23 Formula ions and treatments for well-being

Publications (1)

Publication Number Publication Date
BRPI0518552A2 true BRPI0518552A2 (pt) 2008-12-30

Family

ID=36601288

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518552-1A BRPI0518552A2 (pt) 2004-12-24 2005-12-23 formulaÇço para o bem estar em seres humanos e mÉtodo para aumentar o bem-estar de um paciente humano

Country Status (10)

Country Link
US (2) US7927631B2 (pt)
EP (2) EP1841505A4 (pt)
JP (1) JP2008525320A (pt)
KR (1) KR20070093437A (pt)
BR (1) BRPI0518552A2 (pt)
CA (1) CA2634953C (pt)
MX (1) MX2007007731A (pt)
NZ (1) NZ590209A (pt)
RU (1) RU2007128349A (pt)
WO (1) WO2006066354A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008012988A1 (de) * 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
CN102438634B (zh) * 2009-02-10 2015-01-28 蔡明分 包含银纳米粒和何首乌提取物的组合物及其用途
WO2012006107A2 (en) * 2010-06-28 2012-01-12 Stemtide, Inc. Skin care compositions
CN102552628A (zh) * 2012-01-09 2012-07-11 李承平 一种滋阴补肾的药物组合
US8980339B1 (en) 2013-01-21 2015-03-17 Synertek Colostrum, Inc. Mammalian hair stimulant and growth formula
SG11201704161YA (en) 2014-11-25 2017-06-29 Abbott Lab Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
CN104509861B (zh) * 2014-12-30 2016-08-24 中恩（天津）医药科技有限公司 适于放化疗期肿瘤患者的肠内全营养制剂及其制备方法
CN109640705A (zh) * 2016-08-04 2019-04-16 西雅图咖米公司 矿物质组合物及其制备和使用方法
CN107028834A (zh) * 2017-04-28 2017-08-11 朱立华 一种艾草抗菌组合物及其在沐浴露中的应用
US10183053B1 (en) 2017-06-19 2019-01-22 Gene S. Rosen Multi-component formulations
CN108295240A (zh) * 2018-04-08 2018-07-20 黑龙江军门现代农业发展有限公司 一种补气安神的人参口服液及其制备方法
KR101957502B1 (ko) * 2018-08-17 2019-03-12 이승훈 메틸설포닐메탄을 함유하는 비만, 지방간 및 당뇨병 예방 또는 개선용 조성물

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01261322A (ja) * 1988-04-13 1989-10-18 Akuton Kk 毛髪育成剤
JPH026403A (ja) * 1988-06-24 1990-01-10 Nonogawa Shoji:Kk 頭髪用化粧料および養毛料
GB2240715B (en) * 1990-02-10 1994-01-12 Michael Fuk Yau Wan Composition for treatment of hair and/or scalps and process for its preparation
GB9218714D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Synergistic compositions for hair restoration
JPH0873369A (ja) * 1994-09-01 1996-03-19 Fuairudo:Kk 健康茶
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
AUPN411195A0 (en) * 1995-07-10 1995-08-03 Cathay Herbal Laboratories Pty Ltd Medicinal composition
IT1290347B1 (it) * 1997-02-18 1998-10-22 Horse Vitality Ltd Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento della caduta dei capelli
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US20050196470A9 (en) 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
JP4241958B2 (ja) * 1998-06-12 2009-03-18 第一三共ヘルスケア株式会社 アンドロゲン受容体結合阻害剤
ZA994696B (en) * 1998-09-09 2000-01-31 Pharmachoice Healthcare Pty Lt Nutritional healthcare formulation.
US20040213859A1 (en) * 1999-09-17 2004-10-28 Zelickson Brian D. Organic nutrient for hair loss treatment
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions
WO2002047493A2 (en) 2000-12-16 2002-06-20 Aventis Pharma Deutschland Gmbh Health promoting compositions
KR100392610B1 (ko) * 2000-12-26 2003-07-28 주식회사 에스티씨나라 모발 성장 촉진제 조성물
US20030099725A1 (en) * 2001-02-26 2003-05-29 Global Cancer Strategies Ltd. Herbal compositions useful as chemopreventive and therapeutic agents and methods of manufacturing same
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
CN1336120A (zh) * 2001-08-16 2002-02-20 李利华 活性初乳保健品及其生产方法
KR20010088727A (ko) * 2001-08-27 2001-09-28 - 감기예방 기능을 갖는 건강식품 조성물
WO2003021515A2 (en) * 2001-08-30 2003-03-13 Cheryl Sott Method, apparatus, and system for customizing essential oil and other formulations
JP2003169632A (ja) * 2001-12-08 2003-06-17 Sapuri:Kk 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US20030198685A1 (en) * 2002-04-23 2003-10-23 A. Glenn Braswell Composition and method for increasing testosterone levels
KR20040007174A (ko) 2002-07-13 2004-01-24 이정구 옥타코사놀과 초유등을 배합한 특수영양식품의 제조 방법
US6776979B2 (en) * 2002-12-30 2004-08-17 Marvin B. Frager Periodontal treatment compound and method of use
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US20050250746A1 (en) * 2004-05-06 2005-11-10 Matthew Iammatteo Premenstrual dysphoric disorder medication
US20080206353A1 (en) * 2004-12-24 2008-08-28 Jon Phillips Formulations And Treatments For Trichology

Also Published As

Publication number Publication date
EP2491938A1 (en) 2012-08-29
RU2007128349A (ru) 2009-01-27
EP1841505A4 (en) 2010-01-27
US20080095859A1 (en) 2008-04-24
CA2634953C (en) 2015-09-15
MX2007007731A (es) 2007-10-18
NZ590209A (en) 2012-09-28
EP2491938B1 (en) 2017-08-09
US7927631B2 (en) 2011-04-19
US20110182885A1 (en) 2011-07-28
WO2006066354A1 (en) 2006-06-29
US8475849B2 (en) 2013-07-02
KR20070093437A (ko) 2007-09-18
EP1841505A1 (en) 2007-10-10
CA2634953A1 (en) 2006-06-29
JP2008525320A (ja) 2008-07-17

Similar Documents

Publication Publication Date Title
BRPI0518552A2 (pt) formulaÇço para o bem estar em seres humanos e mÉtodo para aumentar o bem-estar de um paciente humano
WO2003086212A3 (en) Orthopaedic fixation method and device
DE60327089D1 (de) Systeme zum verschieben und/oder zurückhalten von gewebe in den oberen atemwegen
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
IS8105A (is) Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum
BRPI0517948A (pt) método para reduzir fosfato de soro em um paciente com necessidade do mesmo e unidade de dosagem oral
BR112014001295A2 (pt) sistemas e métodos para otimizar o ajuste de um implante à anatomia
BR0110919B1 (pt) método de formação de uma calça pré-fixada e aparelho para o posicionamento de pares de painéis laterais de artigo de vestuário em uma orientação sobreposta.
CY1109480T1 (el) ΠΡΩΤΕΪΝΕΣ ΣΥΝΔΕΣΗΣ Gag
BR112013000027A2 (pt) tratamento de distúrbios cognitivos
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
BRPI0513938B8 (pt) composição farmacêutica contendo drospirenona e etinilestradiol
WO2006110724A3 (en) Method of treating schizophrenia prodrome
BRPI0805167A2 (pt) processo para obtenção de albumina humana de alta eficiência para uso em terapia de desintoxicação
DE60313754D1 (de) Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
BRPI0517782A (pt) formulações de benzotiazol e uso das mesmas
NO20090165L (no) Kombinasjonsfremstillinger innbefattende bifeprunox og L-DOPA
BR0314362A (pt) Método para previnir ou reduzir fraturas secundárias após fratura de quadril
BR0308515A (pt) Combinação de um antagonista de receptor de aldosterona com ácido nicotìnico ou um derivado de ácido nicotìnico
WO2007149816A3 (en) Strontium compositions and methods of treating osteoporotic conditions
SG120937A1 (en) Use of anoectochilus formosanus plant extracts andtheir derived fractions as herbal medicines or nu traceutical supplements for chemoprevention or treatment of human malignancies
UA85548C2 (ru) Применение водного экстракта листьев красного винограда для предупреждения перехода от клинически незначительных ранних стадий хронической венозной недостаточности к i, ii или iii стадии
AR043564A1 (es) Metodo de potenciacion de las habilidades cognitivas
Jalpa et al. Turk J Pharm Sci 2018; 15 (1): 116
CY1110107T1 (el) Συνθεση για την ενεργοποιηση του ανοσοποιητικου συστηματος

Legal Events

Date Code Title Description
B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO 020070085026/RJ DE 22/06/2007.

B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: REFERENTE A RPI 1973 DE 28/10/2008.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]